The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...

Two excellent examples are DexCom (NASDAQ: DXCM ... The Growing Market and Innovation in Continuous Glucose Monitoring (CGM) Technology The WHO estimates […] DXCM faces an FDA warning over ...

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes | Dexcom ...

DexCom, Inc, a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring ... a remote monitoring system; Dexcom Real-Time API, which ...

He described how the system, which consists of two ... Its wearable devices, like the Dexcom G6 and G7, provide real-time glucose monitoring without finger pricks, transmitting data to smartphones ...

Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...